PT  - JOURNAL ARTICLE
AU  - Kagucia, E Wangeci
AU  - Gitonga, John N
AU  - Kalu, Catherine
AU  - Ochomo, Eric
AU  - Ochieng, Benard
AU  - Kuya, Nickline
AU  - Karani, Angela
AU  - Nyagwange, James
AU  - Karia, Boniface
AU  - Mugo, Daisy
AU  - Karanja, Henry K
AU  - Tuju, James
AU  - Mutiso, Agnes
AU  - Maroko, Hosea
AU  - Okubi, Lucy
AU  - Maitha, Eric
AU  - Ajuck, Hossan
AU  - Bogita, Mary
AU  - Mudindi, Richmond
AU  - Mukabi, David
AU  - Moracha, Wycliffe
AU  - Bulimu, David
AU  - Andanje, Nelson
AU  - Shiraku, Evans
AU  - Okuku, Rosemary
AU  - Ogutu, Monicah
AU  - Aman, Rashid
AU  - Mwangangi, Mercy
AU  - Amoth, Patrick
AU  - Kasera, Kadondi
AU  - Ng’ang’a, Wangari
AU  - Mariga, Rodgers
AU  - Munabi, Tobias
AU  - Ramadhan, Susan M
AU  - Mwikali, Janet
AU  - Nasike, Rose
AU  - Andera, Cornelius
AU  - Nechesa, Roselyne
AU  - Kiplagat, Benson K
AU  - Omengo, Julius
AU  - Oteba, Simon
AU  - Mwangi, Arthur
AU  - Mkanyi, Dorcas
AU  - Karisa, George
AU  - Migosi, Judith K
AU  - Msili, Patrick
AU  - Mwambire, Samson
AU  - Boniface, Anthony M
AU  - Nyaguara, Amek
AU  - Voller, Shirine
AU  - Otiende, Mark
AU  - Bottomley, Christian
AU  - Agoti, Charles N
AU  - Ochola-Oyier, Lynette I
AU  - Adetifa, Ifedayo M O
AU  - Etyang, Anthony O
AU  - Gallagher, Katherine E
AU  - Uyoga, Sophie
AU  - Barasa, Edwine
AU  - Bejon, Philip
AU  - Tsofa, Benjamin
AU  - Agweyu, Ambrose
AU  - Warimwe, George M
AU  - Scott, J Anthony G
TI  - Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya
AID  - 10.1101/2021.02.12.21251294
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.12.21251294
4099  - http://medrxiv.org/content/early/2021/02/17/2021.02.12.21251294.short
4100  - http://medrxiv.org/content/early/2021/02/17/2021.02.12.21251294.full
AB  - In October 2020, anti-SARS-CoV-2 IgG seroprevalence among truck drivers and their assistants (TDA) in Kenya was 42.3%, higher than among other key populations. TDA transport essential supplies during the COVID-19 pandemic, placing them at increased risk of being infected and of transmitting SARS-CoV-2 infection over a wide geographical area.Competing Interest StatementRA, MM, KK and PA are from the Ministry of Health, Government of Kenya. All other authors declare no competing interests.Funding StatementThis project was funded by the Wellcome Trust (grants 220991/Z/20/Z and 203077/Z/16/Z), the Bill and Melinda Gates Foundation (INV-017547), and the Foreign Commonwealth and Development Office (FCDO) through the East Africa Research Fund (EARF/ITT/039) and is part of an integrated programme of SARS-CoV-2 serosurveillance in Kenya led by KEMRI-Wellcome Trust Research Programme. The views expressed in this publication are those of the authors and not necessarily those of the funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Kenya Medical Research Institute Scientific and Ethics Review CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data may be requested through the KEMRI-Wellcome Trust Research Programme Data Governance CommitteeCOVID-19Coronavirus disease 2019CPHSCounty public health staffELISAEnzyme-linked immunosorbent assayHCWHealthcare workersNATNucleic acid test/ testingNP/OPNasopharyngeal/ oropharyngealODOptical densityOSBPOne Stop Border PostSARS-CoV-2Severe acute respiratory syndrome coronavirus 2TDATruck drivers and assistants